11th Japanese Safety Pharmacology Society Annual Meeting Program (as of February 20, 2020)
Day 1: Friday, Feb. 28
8:30 〜 18:30 |
Poster Sessions <Kamijo Memorial Hall 4F, Akamatsu> |
8:30 |
Doors open |
10:00 〜 10:10 |
Opening remark Tomoharu Osada President of 11th Annual Meeting |
10:10 〜 11:55 |
Symposium I: Cardiovascular System <Kamijo Memorial Hall 1F, Kamijo Hall>
- Mechanistic insight in drug-induced arrhythmogenicity: CAST-type arrhythmogenicity and LQT-type arrhythmogenicity
Tetsushi Furukawa (Department of Bio-informational Pharmacology, Tokyo Medical and Dental University)
- Molecular mechanism underlying cardiac early afterdepolarization induced by IKr and IKs suppression
Mitsuhiko Yamada (Molecular Pharmacology, Shinshu University School of Medicine Graduate School of Medicine)
- Genetic Predispositions for Sudden Death in Brugata Syndrome Deciphered by Comprehensive Analyses Using Functional Evaluation and Whole-Exome Sequencing
Naomasa Makita (Research Institute, National Cerebral and Cardiovascular Center)
|
11:55 ~ 12:15 |
Coffee Break |
12:15 〜 13:15 |
Luncheon Seminar 1<Kamijo Memorial Hall 1F, Kamijo Hall>
- Improvement of Human Induced Pluripotent Stem Cells for Functional Assessment, Disease Models and Cardio-Oncology
Sponsored by Scrum Inc. / ACEA Biosciences, Inc.
|
13:15 ~ 13:30 |
Coffee Break |
13:30 〜 14:00 |
Flash talk(1-minute BOOTH presentation) <Kamijo Memorial Hall 1F, Kamijo Hall> |
14:00 ~ 14:15 |
Break |
14:15 〜 14:50 |
Invited Lecture I <Kamijo Memorial Hall 1F, Kamijo Hall>
- NOAEL in safety pharmacology: Yes or No?
Tomas Mow (Novo Nordisk A/S, 2020 SPS acting president)
|
14:50 〜 15:20 |
Coffee Break |
15:20 ~ 16:10 |
Flash Talk (1-minute POSTER presentation)<Kamijo Memorial Hall 1F, Kamijo Hall> |
16:10 ~ 16:40 |
Break |
16:40 〜 18:10 |
Poster Presentation Core Time (odd numbers) <Kamijo Memorial Hall 4F, Akamatsu>
|
18:30 〜 20:30 |
Banquet Party Banquet Party has been canceled |
Day 2: Saturday, Feb. 29
8:00 〜 15:30 |
Poster Sessions <Kamijo Memorial Hall 4F, Akamatsu> |
8:00 |
Doors open |
8:30 〜 10:15 |
Symposium II: Central Nervous System <Kamijo Memorial Hall 1F, Kamijo Hall>
- The impact of Safety Pharmacology studies on the development of Siponimod, drug to treat multiple sclerosis
Martin Traebert (Novartis Pharma AG, President of SPS 2019)
- Unveiling immune-brain metabolic interaction by mass spectrometry
Yuki Sugiura (Department of Biochemistry, School of Medicine, Keio University)
- NCNP biobank: From biomarker development to post-marketing study
Kotaro Hattori (Translational Medical Center, National Center of Neurology and Psychiatry)
|
10:15 ~ 10:30 |
Break |
10:30 〜 12:15 |
Special Lecture Artificial Intelligence <Kamijo Memorial Hall 1F, Kamijo Hall>
- Challenges of Artificial Intelligence to Change the Real World
Naohiko Uramoto (Mitsubishi Chemical Holdings Corporation)
- Application of Deep Learning for Drug Discovery
Ryuichiro Ishitani (Preferred Networks, Inc.)
- Prospects for the present and future of artificial intelligence in cardiovascular imaging
Kenya Kusunose (Cardiovascular Medicine, Faculty of Medicine, Tokushima University)
|
12:15 ~ 12:30 |
Break |
12:30 〜 13:30 |
Luncheon Seminar II <Kamijo Memorial Hall 1F, Kamijo Hall>
- Toxicity Signature Analysis – Translational Insights with the Speed and Ease of in vitro Evaluation
- Integrated Cardiac Proarrhythmic Risk Assessment Under The CiPA Initiative
Sponsored by Eurofins Discovery
|
13:30 ~ 14:00 |
Break |
14:00 〜 15:15 |
Poster Presentation Core Time (even numbers) <Kamijo Memorial Hall 4F, Akamatsu>
|
15:15 ~ 15:30 |
Break |
15:30 〜 16:40 |
Symposium III: Case studies of drug development
- Preclinical and clinical profiles of a humanized IL-23 mAb, risankizumab (Skyrizi®)
Hirotaka Tokunaga (AbbVie GK)
- Challenge of the iD3 booster
Nobuyoshi Chiba (Japan Agency of Medical Research and Development (AMED))
|
16:40 〜 17:15 |
Closing
JSPS Award Ceremony Tomoharu Osada (Selection Chairman)
Closing Remarks Yoshiki Deguchi (President of 12th Annual Meeting)
|